Two CD4 oligopeptides, corresponding to residues (37–53) and (37–55) of the V1 domain of CD4, which recent structural studies propose as the most likely binding site of HIV-1 gp120, have been chemically synthesized by solid-phase techniques, modified by the addition of two side-chain protected cysteines at both termini and purified by HPLC. Their ability to inhibit the infectivity of human immunodeficiency virus type 1 (HIV-1) (HTLV-IIIB, RF and GB8 strains) in different cell lines was monitored by the production of progeny virus, p24 and reverse transcriptase activity in the culture supernatants and by electron microscopy. The results indicated that the peptides inhibited HIV-1 infectivity in a dose-dependent fashion without any detectable cytotoxicity.
References
1.
ArthosJ.DeenK.C.ChaikinM.A.FornwaldJ.A.SatheG.SattentauQ.J.ClaphamP.R.WeissR.A.McDougalJ.S.PietropaoloC.AxelR.TrunehA.MaddonP.J., and SweetR.W. (1989) Identification of the residues in human CD4 critical for the binding of HIV. Cell57: 469–481.
2.
AshkenaziA.PrestaL.G.MarstersS.A.CameratoT.R.RosenthalK.A.FendlyB.M., and CaponD.J. (1990) Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis. Proc Natl Acad Sci USA87: 7150–7154.
3.
CaponD.J.ChamowS.M.MordentiJ.MarstersS.A.GregoryT.MitsuyaH.ByrnR.A.LucasC.WurmF.M.GroopmanJ.E.BroderS., and SmithD.H. (1989) Designing CD4 immunoadhesins for AIDS therapy. Nature337: 525–531.
4.
ChaudharyV.K.MizukamiT.FuerstT.FitzGeraldD.J.MossB.PastanI., and BergerG. (1988) Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas axotoxin hybrid protein. Nature335: 369–372.
5.
ClaytonL.K.HusseyR.E.SteinbrichR.RamachandramH.HussainY., and ReinherzE.L. (1988) Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp 120 binding. Nature335: 363–366.
6.
DalgleishA.G.BeverleyP.C.LClaphamP.R.CrawfordD.H.GreavesM.F., and WeissR.A. (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature312: 763–767.
7.
DoyleC., and StromingerJ.L. (1987) Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature330: 256–259.
8.
FiliceG.CeredaP.M., and VarnierO.E. (1988) Infection of rabbits with human immunodeficiency virus. Nature335: 366–369.
9.
GayD.MaddonP.SekalyR.TalleM.A.GodfreyM.LongE.GoldsteinG.ChessL.AxelR.KapplerJ., and MarrackJ. (1987) Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature328: 626–629.
10.
HayashiY.IkutaK.FuJiiN., and Kato (1989) Inhibition of HIV-1 replication and syncytium formation by synthetic CD4 peptides. Arch Virol105: 129–135.
11.
JamesonB.A.A.J.RaoP.E.KongL.E.HahnB.H.ShawG.M.HoodL.E., and KentS.B.H. (1988) Location and chemical synthesis of a binding site for HIV-1 on CD4 protein. Science240: 1335–1339.
12.
KlatzmannD.ChampagneE.ChamaretS.GruestJ.GuetlardD.HercendT.GluckmanJ.C., and MontagnierL. (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature312: 767–768.
13.
LamarreD.AshkenaziA.FleuryS.SmithD.H.SekalyR.P., and CaponD.J. (1989) The MHC-binding and gp120-binding functions of CD4 are separable. Science245: 743–746.
14.
LandauN.R.WartonM., and LittmanD.R. (1988) The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature334: 159–162.
15.
LifsonJ.D.HwangK.M.NaraP.L.FraserB.PadgettM.DunlopN.M., and EidenL.E. (1988) Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. Science241: 712–716.
16.
McDougalJ.S.KennedyM.S.SlighJ.M.CortS.P.MawleA., and NicholsonJ.K.A. (1986) Binding of HTLV-III/LAV to T4+T cells by a complex of the 110K viral protein and the T4 molecule. Science231: 382–385.
17.
MaddonP.J.DalgleishA.G.McDougalJ.S.ClaphamP.E.WeissR.A., and AxelR. (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell54: 65–72.
18.
MizukamiT.FuerstT.R.BergerE.A., and MossB. (1988) Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of CD4 molecule defined by site-directed mutagenesis. Proc Natl Acad Sci USA85: 9273–9277.
19.
NaraP.L.HwangK.M.RauschD.M.LifsonJ.D., and EidenL.E. (1989) CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stage of the viral life cycle. Proc Natl Acad Sci USA86: 7139–7143.
20.
PalùG.MeloniG.A.von BergerJ., and MasottiL. (1986a) On the complex nature of the antiviral activity of coumermycin A1: its interference with the replication of herpes simplex virus type 1. Antiviral Res6: 19–32.
21.
PalùG.PalumboM.AntonelloC.MeloniG.A., and Marciani-MagnoS. (1986b) A search for potential antitumor agents: Biological effects and DNA binding of a series of anthraquinone derivatives. Mol Pharmacol29: 211–217.
22.
PetersonA., and SeedB. (1988) Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell54: 65–72.
23.
ReedL.J., and MuenchH. (1938) A simple method of estimating fifty per cent end points. Am J Hyg27: 493–497.
24.
RyuS.E.KwongP.D.TrunehA.PorterT.J.ArthosJ.RosenbergM.DaiX.XuongN.H.AxelR.SweetR.W., and HendricksonW.A. (1990) Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature348: 419–426.
25.
RobeyE., and AxelR. (1990) CD4: collaborator in immune recognition and HIV infection. Cell60: 697–700.
26.
SattentauQ.J.ArthosJ.DeenK.HannaN.HealyD.BeverleyP.C.L.SweetR., and TrunehA. (1989) Structural analysis of the human immunodeficiency virus-binding domain of CD4. J Exp Med170: 1319–1334.
27.
SleckmanB.P.PetersonA.JonesW.K.ForanJ.A.GreensteinJ.L.SeedB., and BurakoffS.J. (1987) Expression and function of CD4 in a murine T-cell hybridoma. Nature328: 351–353.
28.
TrauneckerA.SchneiderJ.KieferH., and KarjalainenK. (1989) Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules. Nature339: 68–70.
29.
WangJ.YanY.GarrettT.P.J.LiuJ.RodgersD.W.GarlickR.L.TarrG.E.HusainY.ReinherzE.L., and HarrisonS.C. (1990) Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature348: 411–418.
